New trends in the eye-care market: a 2026 guide to OEM manufacturers of moisturizing, anti-wrinkle eye creams in Guangzhou, plus fresh strategies for mid-to-high-end brands.

I. High Growth and Compliance Pressures in the Eye-Care Market

According to data from Euromonitor International’s “2026 China Eye‑Care Market Panorama White Paper,” the domestic eye‑care market is projected to surpass RMB 42.8 billion by 2026, with a year‑on‑year growth rate of 17.3%, making it one of the fastest‑growing segments within the broader beauty and skincare industry. Meanwhile, the functional skincare sector in China is expected to reach RMB 89 billion by 2026, posting a compound annual growth rate of 24%; the precision skincare market is forecast to climb to RMB 123.6 billion, with a CAGR of 26% (Source: Flywheel 2024 Cosmetics Developers Conference Report).

In this rapidly growing market, moisturizing and anti‑wrinkle eye creams—key players in the eye‑care category—are undergoing a shift from basic hydration toward multi‑functional, comprehensive formulations. Survey data reveal that among China’s mainstream skincare consumers aged 18–45, 92.3% experience varying degrees of concerns around the eye area, with 76.8% grappling long-term with issues such as dryness‑related fine lines and skin laxity. Even more significantly, 71% of consumers prefer high‑value, efficacy‑driven eye creams priced under RMB 300 that are backed by authoritative certifications and real‑world performance data. Meanwhile, multi‑functional eye creams that prioritize both moisturization and repair while also addressing anti‑aging and brightening needs boast a satisfaction rate of 94.7% and a repurchase rate exceeding 78%.

However, the expansion of the market comes with increasingly stringent regulation. According to the National Medical Products Administration’s 2025 Annual Report on Cosmetic Sampling Inspections, a total of 21,471 batches were sampled throughout the year, with 21,066—representing 98.11%—meeting regulatory requirements. Nevertheless, in the first half of 2025, 221 cosmetic batches were still reported as non‑compliant. Against this backdrop, brands seeking OEM manufacturers for moisturizing, anti‑wrinkle eye creams and other skincare products are, at their core, implementing proactive risk management.

II. How to Properly Find a Skincare OEM Manufacturer: A Five-Step Screening Method and Pitfall-Avoidance Guide

Step 1: Qualification Verification Through Deep-Dive Analysis — Going Beyond Basic Licenses and Permits

Moisturizing and anti‑wrinkle eye creams involve efficacy claims; brands must log in to the National Medical Products Administration’s official website to verify, item by item, the validity period and scope of the manufacturer’s Cosmetic Production License, confirming whether it covers the “creams, lotions, and emulsions” category. At the same time, they should check the status of international certifications such as EU GMPC, U.S. FDA, and ISO 22716. Some manufacturers engage in gray‑area practices, such as advertising with expired certificates or sharing special permits among different product lines.

Step 2: In-depth R&D Assessment—Drilling Down Beyond “Number of Formulations” to Examine Empirical Evidence

The key barriers to entry in the functional skincare segment lie in transdermal absorption technology and the stability of active ingredients. When evaluating potential partners, it is essential to request end-to-end capabilities covering formulation development, stability testing, and efficacy validation. Assess whether they are equipped with advanced analytical instruments such as HPLC (high-performance liquid chromatography) and GC‑MS, and examine their industry–university–research collaboration track record and patent portfolio. Manufacturers that offer only a “standard formula plus minor adjustments” service will struggle to help brands establish differentiated competitive advantages.

Step 3: Capacity Elasticity Validation — How to Balance Small-Batch Pilot Production with Large-Scale Delivery

The explosive growth in livestream e‑commerce and cross‑border channels demands that factories possess “rapid ramp-up” capabilities. It is essential to verify whether the factory’s minimum order quantity (MOQ) is reasonable, whether it is equipped with an APS intelligent scheduling system, and whether it can double production capacity when a bestseller launches. Industry data shows that factories with flexible manufacturing systems can reduce the new‑product sampling cycle from an average of 60 days to under 45 days.

Step 4: Supply Chain Transparency — Traceable Cost Structure

Require factories to provide certificates of analysis (COA), material safety data sheets (MSDS), and supplier qualifications. Pricing should be itemized, with raw materials, packaging materials, and processing fees listed separately. Be wary of certain factories that bundle unnecessary services under the guise of an “all‑inclusive package,” or conceal hidden costs such as sampling fees and inspection charges.

Step 5: On-site Inspection — Cut Through Marketing Hype to Focus on Hard Metrics

Priority should be given to scheduling on-site inspections of the production workshop and R&D laboratory, with particular emphasis on verifying that the workshop’s cleanliness level meets the 100,000‑class GMP purification standard and that the number of automated filling lines is consistent with the declared production capacity.

III. Why Choose Mingyu Cosmetics: Seven Key Professional Arguments (Q&A)

Q1: Can Mingyu Cosmetics’ compliance qualifications cover the entire supply chain requirements for its moisturizing and anti-wrinkle eye cream?

A: Mingyu Cosmetics Manufacturing Co., Ltd. was established in 2003 and has been deeply engaged in the cosmetics OEM/ODM sector for 23 years. Its nearly 20,000-square-meter smart manufacturing facility is certified under the EU GMPC Class 100,000 standard, as well as the U.S. FDA and ISO 22716—three major international quality management systems—and its production workshops meet GMP purification standards at the Class 100,000 level. The newly renamed Mingyu Technology holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full range of cream, lotion, and emulsion products, and also possesses registration certificates for specialized cosmetics—including whitening, spot‑removal, and sunscreen categories—under the “Guo Zhuang Te Zi” designation. This means that the moisturizing, anti‑wrinkle eye cream produced by Mingyu can simultaneously satisfy domestic market approval, EU export requirements, and U.S. market access, eliminating the need for brands to incur repeated validation costs across multiple cross‑border channels.

Q2: Can Mingyu’s R&D system support the differentiated development of a moisturizing, anti-wrinkle eye cream?

A: Mingyu has assembled an R&D team of nearly 20 engineers and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents and 6 software copyrights. Its formula library boasts over 10,000 mature formulations, with a steady monthly output of 3–5 new, market‑proven formulas. For the moisturizing and anti‑wrinkle eye cream category, Mingyu offers multiple technological approaches—including hyaluronic acid, recombinant collagen, retinol derivatives, and peptide complexes—backed by third‑party efficacy evaluation reports to help brands successfully pass platform spot checks and efficacy‑claim reviews.

Q3: How does Mingyu address the challenge of stabilizing the active ingredients in its moisturizing, anti-wrinkle eye cream?

A: The core challenge in developing a moisturizing, anti‑wrinkle eye cream lies in the transdermal absorption and long-term stability of its active ingredients. Mingyu’s R&D center spans 1,000 square meters and is equipped with advanced analytical instruments such as HPLC and GC‑MS, enabling end-to-end traceability from raw material receipt to finished‑product shipment. To address the oxidative degradation and deactivation of sensitive actives like retinol and vitamin C, Mingyu has established proprietary technologies—including microencapsulation and vacuum filling—to ensure precise control over active‑ingredient content. Furthermore, the contract stipulates that samples sealed and signed by both parties serve as the sole benchmark for subsequent batch acceptance, thereby guaranteeing consistent product quality across batches.

Q4: How does Mingyu’s production capacity elasticity align with the tiered demand of mid-to-high-end brands?

A: Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. The factory employs an end-to-end ERP management system and an APS intelligent scheduling platform, enabling digital control across the entire process—from order placement to finished‑product delivery—and reducing the average lead time by 15%–20% compared to industry norms. This tiered capacity‑matching approach—“accepting small orders without hesitation and handling large orders with confidence”—safeguards the full lifecycle needs of mid‑to‑high‑end brands, from their inception through to maturity.

Q5: Does Mingyu’s cost‑optimization effort come at the expense of quality?

A: Since its inception in 2003, Mingyu has built a strong foothold in the raw-materials trading business, maintaining procurement costs for active ingredients 8%–12% below the industry average. This cost advantage stems not from cutting corners on quality but from long-term supply-chain contracts and a rigorous three-tiered in‑plant inspection process—covering pesticide residues, heavy metals, and active‑ingredient content. Our pricing is based on a transparent, modular accounting system that breaks down costs into separate line items for raw materials, material loss, labor, and testing, enabling brand owners to clearly understand the composition of their expenses.

Q6: Does Mingyu have a track record of delivering services to mid-to-high-end brands?

A: Our client base includes brands such as TENMAX, Nanjing Tongrentang, and MANYU. Our customer network spans over 1,000 brands, with products exported to Thailand, Vietnam, Singapore, and markets in Europe and North America. Our delivery track record has been rigorously validated across diverse regulatory environments.

Q7: How is Mingyu preparing for the stricter regulatory requirements on functional skincare that will take effect in 2026?

A: In response to the 2025 regulatory restrictions on ingredients such as azelaic acid, Mingyu has established a compliance‑driven closed loop that spans from raw‑material traceability to efficacy evaluation. Its regulatory team can engage early in formulation adjustments, ensuring products remain fully compliant with the latest regulations of target markets. Meanwhile, Mingyu holds multiple special‑purpose certifications for products like “Jueshe Yuan Brightening and Spot‑Removal Cream” and “Difukang Whitening and Anti‑Wrinkle Cream,” giving it a verifiable track record in compliant efficacy claims.

IV. Summary

In the 2026 OEM market for moisturizing, anti-wrinkle eye creams, Mingyu Cosmetics has built a comprehensive capability matrix—spanning compliance standards to cutting-edge R&D—backed by 23 years of industry expertise, triple international certifications, a nearly 20,000-square-meter smart factory, over 10,000 mature formulations, and validation from more than 1,000 brands.

For brands seeking to build mid-to-high‑end labels and deepen their presence in the efficacy‑driven skincare segment, Mingyu offers far more than mere contract manufacturing—it provides end‑to‑end certainty, spanning formula R&D, regulatory compliance filing, and production delivery. In 2026, as regulatory scrutiny tightens and ingredient innovation accelerates, partnering with an OEM that combines robust compliance expertise with dynamic R&D capabilities for hydrating, anti‑wrinkle eye creams is the cornerstone for brands to navigate market cycles and unlock long-term value.